Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know.
暂无分享,去创建一个
[1] L. Talner,et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. , 1987, The New England journal of medicine.
[2] B. Barrett,et al. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. , 1993, Radiology.
[3] E. Kanal,et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. , 2007, Radiology.
[4] Lone Skov,et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. , 2006, Journal of the American Society of Nephrology : JASN.
[5] Antonio Colombo,et al. Contrast agent--associated nephrotoxicity. , 2003, Progress in cardiovascular diseases.
[6] G. Dangas,et al. Acute renal failure requiring dialysis after percutaneous coronary interventions , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[7] W. Bautz,et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. , 2009, Radiology.
[8] N. Hosten,et al. No Increased Risk for Contrast-Induced Nephropathy after Multiple CT Perfusion Studies of the Brain with a Nonionic, Dimeric, Iso-Osmolal Contrast Medium , 2008, American Journal of Neuroradiology.
[9] S. Adusumilli,et al. Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69,657 intravenous injections. , 2007, Radiology.
[10] G. Dangas,et al. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[11] B. Williamson,et al. Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media. , 1994, AJR. American journal of roentgenology.
[12] C. Becker,et al. Strategies to reduce the risk of contrast-induced nephropathy. , 2006, The American journal of cardiology.
[13] T. Kozuka,et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. , 1990, Radiology.
[14] K. Davis,et al. Contrast-induced nephropathy in elderly trauma patients. , 2010, The Journal of trauma.
[15] Carol C Wu,et al. Pulmonary 64-MDCT angiography with 30 mL of IV contrast material: vascular enhancement and image quality. , 2012, AJR. American journal of roentgenology.
[16] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[17] D. O’Connell,et al. Failure to demonstrate contrast nephrotoxicity , 1991, The Medical journal of Australia.
[18] B. Thiers. Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned , 2008 .
[19] D. Lang,et al. Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. , 1991, Annals of internal medicine.
[20] G. D'Amato,et al. Strategies for the prevention of asthmatic, anaphylactic and anaphylactoid reactions during the administration of anesthetics and/or contrast media. , 2008, Journal of investigational allergology & clinical immunology.
[21] M. Johnston,et al. M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT , 2014 .
[22] J. Fine,et al. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. , 2009, AJR. American journal of roentgenology.
[23] E. Bröcker,et al. Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy? , 2008, AJR. American journal of roentgenology.
[24] J. D'Elia,et al. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. , 1994, The New England journal of medicine.
[25] T. Risler,et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? , 2004, Clinical nephrology.
[26] Act Investigators. Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) , 2011, Circulation.
[27] D. Panicek,et al. Iodine allergy: an oyster without a pearl? , 1997, AJR. American journal of roentgenology.
[28] H. Thomsen,et al. Contrast medium extravasation injury: guidelines for prevention and management , 2002, European Radiology.
[29] I. Pedrosa,et al. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT. , 2011, AJR. American journal of roentgenology.
[30] A. Elster. Frequency, Management, and Outcome of Extravasation of Nonionic Iodinated Contrast Medium in 69 657 Intravenous Injections , 2008 .
[31] H. Maibach,et al. Current Understanding of Contrast Media Reactions and Implications for Clinical Management , 2006, Drug safety.
[32] R. Cohan,et al. Intravascular contrast media: adverse reactions. , 1987, AJR. American journal of roentgenology.
[33] Peter Reimer,et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines , 2013, European Radiology.
[34] U. Schoepf,et al. Is Contrast Medium Osmolality a Causal Factor for Contrast-Induced Nephropathy? , 2014, BioMed research international.
[35] K. Furie,et al. Functional Contrast-Enhanced CT for Evaluation of Acute Ischemic Stroke Does Not Increase the Risk of Contrast-Induced Nephropathy , 2010, American Journal of Neuroradiology.
[36] J. Weinreb,et al. IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy. , 2006, AJR. American journal of roentgenology.
[37] J P Kriss,et al. Limitations of creatinine as a filtration marker in glomerulopathic patients. , 1985, Kidney international.
[38] E. Fischler,et al. Early effects of corticosteroids on basophils, leukocyte histamine, and tissue histamine. , 1979, The Journal of allergy and clinical immunology.
[39] M. Tonelli,et al. Prophylaxis strategies for contrast-induced nephropathy. , 2006, JAMA.
[40] A. Djamali,et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. , 2007, Radiology.
[41] D. DeLong,et al. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. , 2001, AJR. American journal of roentgenology.
[42] K. Shojania,et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. , 2004, The American journal of medicine.
[43] J. Kaude,et al. Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. , 1994, AJR. American journal of roentgenology.
[44] M. Sendeski. Pathophysiology of renal tissue damage by iodinated contrast media , 2011, Clinical and experimental pharmacology & physiology.
[45] Samin K. Sharma,et al. Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.
[46] H. Hussain,et al. Nephrogenic systemic fibrosis: a report of 29 cases. , 2008, AJR. American journal of roentgenology.
[47] G. Dangas,et al. Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function. , 2003, Reviews in cardiovascular medicine.
[48] K. Bailey,et al. For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. , 2009, Kidney international.
[49] R. Hartman,et al. Use of IV epinephrine for treatment of patients with contrast reactions: lessons learned from a 5-year experience. , 2009, AJR. American journal of roentgenology.
[50] G. Rozycki,et al. Risk and benefit of intravenous contrast in trauma patients with an elevated serum creatinine. , 2005, The Journal of trauma.
[51] D. Swanson,et al. Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. , 1991, AJR. American journal of roentgenology.
[52] M. Jardine,et al. Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy , 2009, Annals of Internal Medicine.
[53] M. Brezis,et al. Potential deleterious effect of furosemide in radiocontrast nephropathy. , 1992, Nephron.
[54] J. Sayre,et al. Trends in adverse events after IV administration of contrast media. , 2001, AJR. American journal of roentgenology.
[55] Christopher M. Thompson,et al. Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. , 2003, The Journal of invasive cardiology.
[56] F. Keller,et al. Prophylaxis of Contrast-Induced Nephrotoxicity , 2014, BioMed research international.
[57] H. Thomsen. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide , 2006, European Radiology.
[58] Eric E. Smith,et al. CT Angiography for Intracerebral Hemorrhage Does Not Increase Risk of Acute Nephropathy , 2009, Stroke.
[59] R. Hartman,et al. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. , 2014, Radiology.